biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Feb 21, 2017 2:26pm

187 Views

Post# 25873076

RE:Jd..this is directly to you...kayacker i have no issue with

drjekyl, beenthere, higgs and common really , just to name a few of the folks here who have been actually RIGHT about the share price and the companys progress for the longest time..

Sorry, but you'll have to kick Jekyl out of that crowd. He was talking about BTI being worth "tens of millions" by now and he predicted a 2016 Q2 buyout.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!